BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 22162478)

  • 1. Genotype-phenotype analysis in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
    Krone N; Reisch N; Idkowiak J; Dhir V; Ivison HE; Hughes BA; Rose IT; O'Neil DM; Vijzelaar R; Smith MJ; MacDonald F; Cole TR; Adolphs N; Barton JS; Blair EM; Braddock SR; Collins F; Cragun DL; Dattani MT; Day R; Dougan S; Feist M; Gottschalk ME; Gregory JW; Haim M; Harrison R; Olney AH; Hauffa BP; Hindmarsh PC; Hopkin RJ; Jira PE; Kempers M; Kerstens MN; Khalifa MM; Köhler B; Maiter D; Nielsen S; O'Riordan SM; Roth CL; Shane KP; Silink M; Stikkelbroeck NM; Sweeney E; Szarras-Czapnik M; Waterson JR; Williamson L; Hartmann MF; Taylor NF; Wudy SA; Malunowicz EM; Shackleton CH; Arlt W
    J Clin Endocrinol Metab; 2012 Feb; 97(2):E257-67. PubMed ID: 22162478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pubertal presentation in seven patients with congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
    Idkowiak J; O'Riordan S; Reisch N; Malunowicz EM; Collins F; Kerstens MN; Köhler B; Graul-Neumann LM; Szarras-Czapnik M; Dattani M; Silink M; Shackleton CH; Maiter D; Krone N; Arlt W
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E453-62. PubMed ID: 21190981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450 oxidoreductase deficiency: rare congenital disorder leading to skeletal malformations and steroidogenic defects.
    Fukami M; Ogata T
    Pediatr Int; 2014 Dec; 56(6):805-808. PubMed ID: 25294558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P450 Oxidoreductase deficiency: Analysis of mutations and polymorphisms.
    Burkhard FZ; Parween S; Udhane SS; Flück CE; Pandey AV
    J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):38-50. PubMed ID: 27068427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal diagnosis of congenital adrenal hyperplasia caused by P450 oxidoreductase deficiency.
    Reisch N; Idkowiak J; Hughes BA; Ivison HE; Abdul-Rahman OA; Hendon LG; Olney AH; Nielsen S; Harrison R; Blair EM; Dhir V; Krone N; Shackleton CH; Arlt W
    J Clin Endocrinol Metab; 2013 Mar; 98(3):E528-36. PubMed ID: 23365120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined homozygous 21 hydroxylase with heterozygous P450 oxidoreductase mutation in a Saudi boy presented with hypertension.
    Aljabri A; Alnaim F; Alsaleh Y
    BMJ Case Rep; 2020 Sep; 13(9):. PubMed ID: 32994263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic challenges and management advances in cytochrome P450 oxidoreductase deficiency, a rare form of congenital adrenal hyperplasia, with 46, XX karyotype.
    Wang C; Tian Q
    Front Endocrinol (Lausanne); 2023; 14():1226387. PubMed ID: 37635957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
    Zhang J; Woo KL; Hai Y; Wang S; Lin Y; Huang Y; Peng X; Wu H; Zhang S; Yan L; Li Y
    Front Endocrinol (Lausanne); 2022; 13():1020880. PubMed ID: 36518257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 oxidoreductase deficiency in three patients initially regarded as having 21-hydroxylase deficiency and/or aromatase deficiency: diagnostic value of urine steroid hormone analysis.
    Fukami M; Hasegawa T; Horikawa R; Ohashi T; Nishimura G; Homma K; Ogata T
    Pediatr Res; 2006 Feb; 59(2):276-80. PubMed ID: 16439592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel phenotypes and genotypes in Antley-Bixler syndrome caused by cytochrome P450 oxidoreductase deficiency: based on the first cohort of Chinese children.
    Fan L; Ren X; Song Y; Su C; Fu J; Gong C
    Orphanet J Rare Dis; 2019 Dec; 14(1):299. PubMed ID: 31888681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of congenital adrenal hyperplasia.
    Krone N; Arlt W
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):181-92. PubMed ID: 19500762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical, genetic, and enzymatic characterization of P450 oxidoreductase deficiency in four patients.
    Sahakitrungruang T; Huang N; Tee MK; Agrawal V; Russell WE; Crock P; Murphy N; Migeon CJ; Miller WL
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4992-5000. PubMed ID: 19837910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired hepatic drug and steroid metabolism in congenital adrenal hyperplasia due to P450 oxidoreductase deficiency.
    Tomalik-Scharte D; Maiter D; Kirchheiner J; Ivison HE; Fuhr U; Arlt W
    Eur J Endocrinol; 2010 Dec; 163(6):919-24. PubMed ID: 20844025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In Silico Analysis of PORD Mutations on the 3D Structure of P450 Oxidoreductase.
    Nurhafizuddin M; Azizi A; Ming LC; Shafqat N
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P450 oxidoreductase deficiency - a new form of congenital adrenal hyperplasia.
    Flück CE; Pandey AV; Huang N; Agrawal V; Miller WL
    Endocr Dev; 2008; 13():67-81. PubMed ID: 18493134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Congenital adrenal hyperplasia, disorders of sex development, and infertility in patients with POR gene pathogenic variants: a systematic review of the literature.
    Gusmano C; Cannarella R; Crafa A; Barbagallo F; La Vignera S; Condorelli RA; Calogero AE
    J Endocrinol Invest; 2023 Jan; 46(1):1-14. PubMed ID: 35842891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P450 Oxidoreductase Deficiency: A Systematic Review and Meta-analysis of Genotypes, Phenotypes, and Their Relationships.
    Dean B; Chrisp GL; Quartararo M; Maguire AM; Hameed S; King BR; Munns CF; Torpy DJ; Falhammar H; Rushworth RL
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31825489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel large CYP17A1 deletion by MLPA analysis in a family with classic 17α-hydroxylase deficiency.
    Turkkahraman D; Guran T; Ivison H; Griffin A; Vijzelaar R; Krone N
    Sex Dev; 2015; 9(2):91-7. PubMed ID: 25765894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A missense mutation in the human cytochrome b5 gene causes 46,XY disorder of sex development due to true isolated 17,20 lyase deficiency.
    Idkowiak J; Randell T; Dhir V; Patel P; Shackleton CH; Taylor NF; Krone N; Arlt W
    J Clin Endocrinol Metab; 2012 Mar; 97(3):E465-75. PubMed ID: 22170710
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.